Re "Marketing of 'low-T' drugs concerns doctors" (Page A11, Oct. 16): The article misinforms readers about hormone therapy for men. Low testosterone does indeed lead to weakness, depression, diminished muscle mass, higher incidence of cardiovascular disease, metabolic syndrome, and erectile dysfunction, and is the major cause of male osteoporosis.
Likewise, studies show that estrogen per se does not cause breast cancer. It is well-known to menopause specialists that when estrogen therapy is initiated within five years of menopause, risks of cardiovascular death and cognitive decline are 30 percent less, and the risk of osteoporosis mostly vanishes.
As for misuse or abuse, any drug, including alcohol and over-the-counter supplements, have this potential. I suggest writers consult with a specialist when writing about hormone therapy.
-- Michael Goodman, M.D., Davis